Investments and investor services
Aim 100 index halves week's losses
Aim's leading lights ended a rough week on a bright note
Company
Scancell Holdings PLC
LON:SCLP
Scancell is a clinical stage biotech company developing immunotherapies for a cancer-free future by enhancing long-lasting tumour specific immunity. With deep roots in cancer immunology and translational research, the company aims to translate its innovation and creativity to address the need for fast, potent and accessible therapies that are easy to administer in hard-to-treat cancers.
329 stories · page 16 of 17
Small caps higher at lunch but blue chip brother higher
Junior oilers were making ground as small cap indices went higher but were still left in the rear view mirror by FTSE100.
Investments and investor services
The Footsie rockets higher, overshadowing Aim's rise
Avanti Communications was a high flyer on Aim but the junior market had to cede the spotlight to the big guns this morning
Risers & Fallers: Minoan PLC, Forbidden Technologies PLC, Cambian PLC ...
Main share price risers and fallers in London at 4.15pm
Scancell Holdings PLC teams up with Sweden's leading research organisation
Discussions with the rheumatology unit at Karolinska Institutet will explore the role of citrullinated proteins in the treatment of cancer.
Archive
Investors waiting on Draghi
It was a day to take the bus with Proxama and get off the Tandem
Scancell PLC fund raise well-backed as trial pace quickens
A hot area of cancer research at present, immunotherapy uses the body's own internal biological defences to ward off the disease,
Risers & Fallers, including Cairn Energy PLC, Metal Tiger PLC, UK Oil & Gas PLC ...
Here are some significant movers at around 2.00pm midweek....
Archive
Proactive news summary: dotDigital, Image Scan Holdings, Pan African Resources, TyraTech and more.
Biotech group Scancell is to present an update on its immunotherapy technologies at the Biotech Capital Conference in London.
Immunotherapies: "The way forward for cancer treatment"
We talk to Dr Richard Goodfellow of Scancell whose researchers are developing a medicine that uses the body’s own defences to cure itself.
Archive
Proactive news summary: Premier African Minerals, Eurasia Mining, Sirius Minerals, Blur Group ...
Mining featured predominantly in the news again Wendesday.
Scancell results track its exciting transformation
Among the landmarks were the data from the phase I/II clinical trial of SCIB1 from the ImmunoBody platform, which delivered extraordinary results for patients with hard to treat melanoma.
Investments and investor services
Footsie falls but Laird sparks investor interest
Electronics group sparked up on potential interest from US rival
Investments and investor services
Risers & Fallers: Wishbone Gold, Satellite Solutions Worldwide, Octagonal and more
Precious metal explorer Wishbone said it was in talks to buy a "complementary business"
Risers & fallers: KImberley, RedT, TP Group, Shoezone..
Some of the main share price movers in London at 1.30pm
Scancell to use cutting-edge diagnostic in cancer trial
ImmunTraCkeR will be used to identify the patients who will benefit most from the cutting edge immunotherapy.
Investments and investor services
Proactive news highlights: Breedon Aggregates, First Property, JKX Oil and more
Forte Energy, Ferrexpo and MX Oil were also in the news on Thursday
Scancell's US focus underlined by change of chairman
David Evans, outgoing chairman, said: "I have thoroughly enjoyed my eight years as chairman of Scancell and I am proud of its many accomplishments."
Proactive news highlights: Imaginatik, Corero Network, Scancell Holdings and more
Motive Television, VolitionRx and Jersey Oil & Gas were also in the news
Scancell hails 'ringing endorsement' of its cancer technology
A paper in Cancer Research, a leading journal for doctors and surgeons specialising in this area of medicine, outlined the company’s innovative approach to generating vaccines that fight the disease.